The Heartland Institute

  • Texas AG Sues Drug Makers for Adulterated ADHD Drugs for Children

    Texas Attorney General Ken Paxton is suing drug manufacturers Pfizer and Tris Pharma for misrepresenting a drug to treat attention-deficit/hyperactivity disorder (ADHD) they claimed complied with Food and Drug Administration regulations, that was adulterated. Tris was under contract with Pfizer to manufacture the ADHD drug Quillivant XR for children enrolled in Medicaid. The Texas AG’s…

  • Michigan Physicians Call Out Corporate Practice of Medicine

    The Michigan State Medical Society (MSMS) is urging State Attorney General Dana Nessel to investigate violations of a state law prohibiting unlicensed corporations from owning medical practices. MSMS sent a five-page letter to Nessel on October 23 stating that private equity groups have used a “series of deceptive legal loopholes” in states, including Michigan, to…

  • Republicans Face Challenges on Health Care in 2024 Election

    A survey by the progressive Navigator political research group found that three in five American voters view the Affordable Care Act (ACA) favorably, more people trusted the Democratic Party on health care issues, and most voters believe a Republican president would repeal Obamacare. Navigator sampled 1,000 registered voters online from November 30 to December 4,…

  • ‘March-in” Policy Threatens Research for Rare Disease Treatment

    The federal government is moving forward with controlling drug costs by approving “march-in” authority on drug pricing. The Biden administration announced on December 7 that it would be directing government entities to employ the “march-in” clause under the Patent and Trademark Act Amendments, also called the Bayh-Dole Act, to curb the pricing of certain medications.…

  • Fetal Tissue Experiments Under Federal Investigation

    The alleged illegal harvesting of body parts from late-term aborted babies at the University of Pittsburgh (UP) is at the center of a two-year-old investigation by the U.S. Department of Health and Human Service’s Office of Inspector General (OIG), recently obtained emails confirm. OIG investigators are said to be focusing on lab experiments conducted from…

  • Racial Quotas for State Medical Boards Under Fire

    The nonprofit organization Do No Harm is challenging a 35-year-old law in Tennessee that requires the governor to appoint members to state licensing boards based on racial quotas in a lawsuit filed in the U.S. District Court for the Middle District of Tennessee, Nashville Division. The complaint claims Tenn. Code 8-1-111 and 63-3-103 (b) violate…

  • Florida Surgeon General Calls for Halt to COVID-19 Shots

    Florida Surgeon General Joseph Ladapo called for a halt in the use of the Pfizer and Moderna COVID-19 mRNA shots on January 3, after the Food and Drug Administration and the Centers for Disease Control and Prevention did not respond to his questions on reports of DNA plasmid contaminants and oncogenic SV40 promoter genes, stated…

  • Study Raises Questions About the Safety of mRNA Shots

    A study in the journal Nature is raising alarms about just how much wasn’t known about the mRNA shots for COVID-19 before billions of people received them. The study, titled “N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting,” was published on December 5 and had 20 authors, led by researchers at Cambridge University’s Medical Research Center…

  • Physician Sues New Jersey Over Bar on Out-of-State Telehealth

    A Boston-based physician who specializes in the treatment of rare childhood cancers is suing the New Jersey State Board of Medical Examiners for barring out-of-state physicians from telehealth consultations with Garden State patients across state lines. The case, Shannon MacDonald, M.D., et al. v. Otto Sabando, filed in the U.S. District Court for New Jersey,…

  • Genetic Test for Opioid Addiction Wins FDA Approval

    Patients now have access to a prescription genetic test that could indicate their risk of opioid use disorder (OUD) before beginning treatment with an opioid pain medication. The Food and Drug Administration (FDA) approved AvertD, the first test of its kind, on December 19. The test, manufactured by AutoGenomics, Inc., can be used before a…

Latest Issue – December 2025

2025 Archived Editions: Jan, Feb, Mar, Apr, May, Jun, Aug, Sep, Oct, Dec

2024 Archived Editions: Jan, Feb, Mar, Apr, May, June Aug, Sept, Oct, Nov

2023 Archived Editions: Jan, Feb, Mar, Apr, May, Jun, Aug, Sep, Oct, Nov 

2022 Archived Editions: Jan, Feb, Mar, Apr, May, July, Aug, Sept, Oct, Nov

2021 Archived Editions: Jan, Feb, Mar, Apr, May, June, July, Aug, Sept, Oct, Nov

2020 Archived Editions: Jan, Mar, Apr, Jun, Jul, Aug, Sep, Oct, Nov, Dec

For back issues and articles published before January 2020, click here.